Experts discuss the importance of initiating blinatumomab treatment for acute lymphoid leukemia in academic centers for ...

The Chronic Lymphocytic Leukemia Market is set for significant expansion over the next decade. Valued at USD 5.4 billion in 2025, the market is projected to grow to USD 10.3 billion by 2035, ...

Acalabrutinib plus obinutuzumab shows superior long-term outcomes in treatment-naive chronic lymphocytic leukemia.

Here's how to systematize curiosity in your own marketing practice: • Test assumptions. Before developing any strategy, ...

Bristol Myers BMY recently announced that it will acquire privately held biotechnology company Orbital Therapeutics for $1.5 ...

AstraZeneca has agreed to lower prescription drug costs for Medicaid under a deal with the Trump administration.

Glowing lanterns will be filling Portland's South Waterfront for The Leukemia and Lymphoma Society's 'Light the Night' event ...

The U.S. Food and Drug Administration (FDA) has granted fast track designation to UB-VV111 for the treatment of ...

NRIX stock is rated Strong Buy as bexobrutideg advances in CLL trials. See here for NRIX stock's milestones, market potential ...

Hundreds of people once again grabbed lanterns (and rain jackets) to once again to Light The Night in Portland.

A new tool developed by Weill Cornell Medicine and the University of Adelaide investigators has enhanced the ability to track ...

Blood Cancer United, which was formerly known as the Leukemia & Lymphoma Society, has created a way for blood cancer patients ...